Preterm Labor Clinical Trials

13 recruitingLast updated: June 18, 2026

There are 13 actively recruiting preterm labor clinical trials across 8 countries. Studies span Not Applicable, Phase 1, Phase 4. Top locations include Nahariya, Israel, Afula, Israel, Ashkelon, Israel. Updated daily from ClinicalTrials.gov.


Preterm Labor Trials at a Glance

13 actively recruiting trials for preterm labor are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Not Applicable with 6 trials, with the heaviest enrollment activity in Nahariya, Afula, and Ashkelon. Lead sponsors running preterm labor studies include Copenhagen University Hospital, Hvidovre, Indiana University, and Assistance Publique - Hôpitaux de Paris.

Browse preterm labor trials by phase

Treatments under study

About Preterm Labor Clinical Trials

Looking for clinical trials for Preterm Labor? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Preterm Labor trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Preterm Labor clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 113 of 13 trials

Recruiting
Phase 1

Pharmacokinetics and Placental Transfer of Caffeine

Apnea of PrematurityPremature BirthBronchopulmonary Dysplasia+2 more
Indiana University30 enrolled1 locationNCT07570121
Recruiting

Uterine Artery Doppler Indices and Uterocervical Angle Measurment in Prediction of Preterm Labor

Preterm Labor
Kafrelsheikh University47 enrolled1 locationNCT07336173
Recruiting
Not Applicable

The Combined Effect of Magnesium, Palmitoylethanolamide, High-Molecular-weight Hyaluronic Acid, Vitamin B6, and Vitamin D in Preventing Preterm Birth:

Preterm Labor
University of Roma La Sapienza150 enrolled1 locationNCT07305519
Recruiting

The Combined First Trimester Screening

Fetal Growth RestrictionPreterm LaborPreeclampsia (PE)+4 more
Institute of Health Information and Statistics of the Czech Republic2,000 enrolled3 locationsNCT07015203
Recruiting

PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients)

Pre-EclampsiaPre-Eclampsia; Complicating PregnancyART+12 more
Copenhagen University Hospital, Hvidovre462 enrolled6 locationsNCT07263490
Recruiting

Prospective Data Bank Creation to Study Vaginal Conditions

VulvodyniaPreterm LaborBacterial vaginosis+1 more
Texas Tech University Health Sciences Center550 enrolled1 locationNCT01829204
Recruiting
Not Applicable

Development and Clinical Evaluation of an Innovative Medical Device to Predict Preterm Birth (PrediMAP)

Preterm Labor
Assistance Publique - Hôpitaux de Paris3,600 enrolled1 locationNCT05586334
Recruiting
Not Applicable

Comparing Two Prophylactic Antibiotic Protocols in Women With Term Prolonged Pre-labor Rupture of Membrane and Preterm Labor

Preterm Labor With Preterm DeliveryPremature Rupture of Membranes Prolonged
Western Galilee Hospital-Nahariya600 enrolled1 locationNCT05469984
Recruiting
Not Applicable

Maternal Stress on Human Milk and Infant Outcomes

Preterm LaborPostpartum Depression
University of Idaho500 enrolled1 locationNCT04821544
Recruiting
Not Applicable

FB-CT2 Includes Two Prospective, Multi-centre Studies With a Medical Device in Hospital Settings: a Randomized, Dual-arm, Open-label Pilot Study in Spain, Followed by a Single-arm, Non-randomized, Open-label International Pivotal Study

Threatened Preterm Labor
Ultrasound-Innovation Medtech, S.L.457 enrolled14 locationsNCT06968364
Recruiting

Blood Glucose in Pregnant Non-diabetic Women During Treatment With Betamethasone for Fetal Lung Maturation

HyperglycemiaPreterm BirthNeonatal Hypoglycemia+1 more
University of Aarhus25 enrolled1 locationNCT06794307
Recruiting
Not Applicable

Low Dose Antenatal Corticosteroids for Late Preterm Delivery

Preterm LaborRespiratory Morbidity
Rambam Health Care Campus1,510 enrolled16 locationsNCT05698966
Recruiting
Phase 4

Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA

Preterm LaborPreterm BirthRupture of Membranes; Delayed Delivery (Following Spontaneous Rupture)+3 more
Woman's34 enrolled1 locationNCT04047849